Aquestive Therapeutics Ownership | Who Owns Aquestive Therapeutics?
Aquestive Therapeutics Ownership Summary
Aquestive Therapeutics is owned by 47.89% institutional investors, 4.39% insiders, and 47.72% retail investors. Bratton capital management is the largest institutional shareholder, holding 10.77% of AQST shares. Vanguard US Total Market Shares ETF is the top mutual fund, with 2.43% of its assets in Aquestive Therapeutics shares.
AQST Ownership Benchmark
Type | Name | % Inst | % Insiders | % Retail |
---|---|---|---|---|
Stock | Aquestive Therapeutics | 47.89% | 4.39% | 47.72% |
Sector | Healthcare Stocks | 488.17% | 11.08% | -399.26% |
Industry | Specialty & Generic Drug Manufacturers Stocks | 43.51% | 11.55% | 44.95% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
Holder | Shares | % Holding | Value |
---|---|---|---|
Bratton capital management | 9.81M | 10.77% | $34.93M |
Blackrock | 5.45M | 7.41% | $14.18M |
Blackrock funding, inc. /de | 6.48M | 6.52% | $21.44M |
Vanguard group | 4.35M | 4.77% | $15.47M |
Perceptive advisors | 2.19M | 2.21% | $7.25M |
Geode capital management | 1.65M | 1.82% | $5.89M |
Pale fire capital se | 1.68M | 1.69% | $5.55M |
State street | 1.50M | 1.65% | $5.35M |
Janney montgomery scott | 880.49K | 1.20% | $2.29M |
Goldman sachs group | 876.54K | 0.96% | $3.12M |
Top Institutional Shareholders by % of Total Assets
Holder | Shares | % Assets | Value |
---|---|---|---|
Bratton capital management | 9.81M | 100.00% | $34.93M |
Sio capital management | 947.49K | 1.20% | $3.14M |
Blue owl capital lp | 920.00K | 0.98% | $3.05M |
Latash investments | 243.13K | 0.62% | $804.77K |
Pale fire capital se | 1.68M | 0.57% | $5.55M |
Diametric capital, lp | 165.37K | 0.29% | $547.38K |
Perceptive advisors | 2.19M | 0.27% | $7.25M |
Harvey capital management | 333.75K | 0.27% | $1.13M |
Cahill wealth management | 143.05K | 0.26% | $509.26K |
Entrypoint capital | 149.16K | 0.25% | $493.71K |
Top Buyers
Holder | Shares | % Assets | Change |
---|---|---|---|
Blackrock | 5.45M | 0.00% | 4.11M |
Goldman sachs group | 876.54K | 0.00% | 653.85K |
Sio capital management | 947.49K | 1.20% | 555.86K |
Blackrock funding, inc. /de | 6.48M | 0.00% | 540.85K |
Janney montgomery scott | 880.49K | 0.01% | 538.63K |
Top Sellers
Holder | Shares | % Assets | Change |
---|---|---|---|
Vr adviser | - | - | -2.63M |
Franklin resources | - | - | -2.13M |
Bioimpact capital | - | - | -1.61M |
Laurion capital management lp | - | - | -1.55M |
Perceptive advisors | 2.19M | 0.27% | -1.54M |
New Positions
Holder | Shares | % Assets | Change | Value |
---|---|---|---|---|
Financial engines advisors | 272.69K | 0.00% | 272.69K | $903.00K |
Centiva capital, lp | 63.95K | 0.00% | 63.95K | $211.68K |
China universal asset management | 19.33K | 0.01% | 19.33K | $68.83K |
Daymark wealth partners | 17.50K | 0.00% | 17.50K | $57.92K |
First national bank & trust co of newtown | 15.00K | 0.01% | 15.00K | $49.50K |
Sold Out
Holder | Change |
---|---|
National bank of canada /fi/ | -4.00 |
Ifp advisors | -10.00 |
Coppell advisory solutions | -16.00 |
True wealth design | -47.00 |
Northwestern mutual wealth management | -50.00 |
Institutional Ownership Trends
Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
---|---|---|---|---|---|---|---|---|---|---|
Jun 30, 2025 | 118 | -5.60% | 47,569,617 | 7.50% | 47 | 2.23% | 66 | -9.59% | 26 | -13.33% |
Mar 31, 2025 | 125 | 5.93% | 44,252,862 | 2.02% | 46 | 2.04% | 73 | 8.96% | 30 | -6.25% |
Dec 31, 2024 | 117 | -4.10% | 43,374,494 | -7.27% | 47 | 1.81% | 66 | -15.38% | 32 | 33.33% |
Sep 30, 2024 | 122 | 23.23% | 46,774,772 | 10.17% | 51 | 1.54% | 79 | 31.67% | 23 | - |
Jun 30, 2024 | 99 | -3.88% | 42,456,890 | 2.32% | 57 | 1.26% | 60 | -18.92% | 23 | 64.29% |
Top Mutual Funds Shareholders
Holder | Shares | % Holding | Change |
---|---|---|---|
Vanguard US Total Market Shares ETF | 2.40M | 2.43% | - |
Vanguard Total Stock Mkt Idx Inv | 2.35M | 2.37% | -52.26K |
iShares Russell 2000 ETF | 2.05M | 2.06% | -38.95K |
Fidelity Small Cap Index | 861.98K | 0.87% | 108.98K |
Vanguard Institutional Extnd Mkt Idx Tr | 855.73K | 0.86% | -400.11K |
Invesco Dorsey Wright SmallCap Momt ETF | 775.69K | 0.85% | 1.41K |
Nuveen Equity Index R6 | 649.35K | 0.71% | - |
Franklin Biotechnology Discv A(acc)USD | 521.70K | 0.57% | -821.40K |
MEDICAL BioHealth EUR Acc | 485.29K | 0.53% | - |
iShares Russell 2000 Value ETF | 491.19K | 0.49% | 364.00 |
Recent Insider Transactions
Date | Name | Role | Activity | Value |
---|---|---|---|---|
Sep 04, 2025 | Jung Cassie | Chief Operating Officer | Sell | $310.90K |
Sep 05, 2025 | Boyd Peter E. | See Remarks | Sell | $79.50K |
Nov 26, 2024 | Jung Cassie | Chief Operating Officer | Sell | $214.06 |
Mar 15, 2024 | Schobel Alexander Mark | Chief Innovation/Tech Officer | Sell | $300.00K |
Mar 08, 2024 | Schobel Alexander Mark | Chief Innovation/Tech Officer | Sell | $129.69K |
Insider Transactions Trends
Date | Buy | Sell |
---|---|---|
2025 Q3 | - | - |
2025 Q2 | - | - |
2025 Q1 | - | - |
2024 Q4 | - | 1 |
2024 Q3 | - | - |
AQST Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools